Arene Life Sciences (Unit 3) Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2006.

2006 Hyderabad, Telangana, India Active

Last Updated: January 01, 2026

About Arene Life Sciences (Unit 3) Private Limited

Arene Life Sciences (Unit 3) Private Limited, a active private limited company, was established on 20 February 2006 in Hyderabad, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24239TG2006PTC049202. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹12.00 Cr and a paid-up capital of ₹10.83 Cr.

Formerly known as A V R Organics Private Limited. It upholds a compliant status. Employing 368 professional, Its leadership includes Satyanarayana Reddy Khairtabad (Director), Santosh Reddy Chinnamail (Director), Khairtabad Anuraag Reddy (Director). Past directors included Vittal Reddy Vittalreddigari, Anjireddy Chinnamail, Satyanarayana Reddy Khairtabad. It holds ₹143.40 Cr open charges and ₹43.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No.3-58, S.R. Chambers R.C.Puram Main Road,, Hyderabad, Telangana, 502032.

Company Details

CIN/LLPIN
U24239TG2006PTC049202
Registration Number
049202
Incorporation Date
20 February 2006
Authorized Capital
₹12.00 Cr
Paid-Up Capital
₹10.83 Cr
ROC Code
Roc Hyderabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 12.00 Cr as on 01-01-2026
Paid Up Capital ₹ 10.83 Cr as on 01-01-2026
Company Age 19 Year, 11 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 143.40 Cr as on 01-01-2026
Satisfied Charges ₹ 43.00 Cr as on 01-01-2026
Revenue Growth **** 2.87% (FY 2023)
Profit Growth **** -36.62% (FY 2023)
Ebitda **** -26.26% (FY 2023)
Net Worth 14.50% (FY 2023)
Total Assets **** 29.63% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Arene Life Sciences (Unit 3) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Arene Life Sciences (Unit 3) Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Satyanarayana Reddy Khairtabad	Director	02 Sep 2017	Current
Santosh Reddy Chinnamail	Director	19 Feb 2020	Current
Khairtabad Anuraag Reddy	Director	19 Feb 2020	Current
Purushotam Angalagutha	Director	04 Jan 2018	Current
Satyanarayana Reddy Chinnamail	Director	02 Sep 2017	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	26 Apr 2018	Past
Pramod Abcsdd	Director	26 Apr 2018	Past
Pramod Abcsdd	Additional Director	29 Sep 2017	Past
Pramod Abcsdd	Additional Director	28 Sep 2018	Past
Pramod Abcsdd	Additional Director	29 Sep 2017	Past
Pramod Abcsdd	Company Secretary	-	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Arene Life Sciences (Unit 3).

Arene Life Sciences (Unit 3) Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.87% increase. The company also saw a substantial fall in profitability, with a 36.62% decrease in profit. The company's net worth Soared by an impressive increase of 14.5%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

2.87%

*******

Revenue from Operations

*******

2.22%

*******

Total Assets

*******

29.63%

*******

Profit or Loss

*******

-36.62%

*******

Net Worth

*******

14.50%

*******

EBITDA

*******

-26.26%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Arene Life Sciences (Unit 3)?

In 2023, Arene Life Sciences (Unit 3) had a promoter holding of 73.71% and a public holding of 26.29%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹1,434,000,000.00

Satisfied Charges

₹430,000,000.00

Charges Breakdown by Lending Institutions

Hdfc Bank Limited : 66.30 Cr
Karnataka Bank Ltd. : 57.10 Cr
Others : 20.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
22 Apr 2025	Hdfc Bank Limited	₹3.00 M	Open
11 Apr 2025	Others	₹20.00 Cr	Open
30 Dec 2021	Karnataka Bank Ltd.	₹8.90 Cr	Open
24 Sep 2021	Hdfc Bank Limited	₹66.00 Cr	Open
21 Apr 2020	Karnataka Bank Ltd.	₹48.20 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Arene Life Sciences (Unit 3)?

Arene Life Sciences (Unit 3) has a workforce of 368 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Arene Life Sciences (Unit 3), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arene Life Sciences (Unit 3)'s trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Arene Life Sciences (Unit 3)

Recent Activity within the Organization

Director Appointment

The activity Nikita Bhandari was appointed as a Company Secretary was appointed as a Company Secretary on 15 Jul 2025 & has been associated with this company since 7 months 2 days . was completed.
15 Jul 2025
Charges

Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.30 Cr with Charge ID 101087177 was registered on 22 Apr 2025. was documented.
22 Apr 2025
Charges

A charge with Others amounted to Rs. 20.00 Cr with Charge ID 101076839 was registered on 11 Apr 2025. was recorded as a recent event.
11 Apr 2025
Annual General Meeting

Progress on Arene Life Sciences (Unit 3) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
30 Sep 2024
Balance Sheet

Progress on Arene Life Sciences (Unit 3) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
31 Mar 2024
Director Appointment

Progress on Sivanaga Mani Vallakati was appointed as a Company Secretary was appointed as a Company Secretary on 01 Apr 2023 & has been associated with this company since 2 years 10 months . was documented.
01 Apr 2023

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Arene Life Sciences (Unit 3) Private Limited?

The CIN of Arene Life Sciences (Unit 3) Private Limited is U24239TG2006PTC049202.

Where is Arene Life Sciences (Unit 3) Private Limited headquartered?

Arene Life Sciences (Unit 3) Private Limited is headquartered at No.3-58, S.R. Chambers R.C.Puram Main Road,, Hyderabad, Telangana, 502032.

When was Arene Life Sciences (Unit 3) Private Limited incorporated?

Arene Life Sciences (Unit 3) Private Limited was incorporated on 20 February 2006.

Who are the current directors of Arene Life Sciences (Unit 3) Private Limited?

The current directors of Arene Life Sciences (Unit 3) Private Limited are

What is the primary industry of Arene Life Sciences (Unit 3) Private Limited?

The primary industry of Arene Life Sciences (Unit 3) Private Limited is Manufacturing.

Is Arene Life Sciences (Unit 3) Private Limited a listed company?

Arene Life Sciences (Unit 3) Private Limited is unlisted.

What is the capital structure of Arene Life Sciences (Unit 3) Private Limited?

The authorized capital of Arene Life Sciences (Unit 3) Private Limited is ₹12.00 Cr, and the paid-up capital is ₹10.83 Cr.

What is the compliance status of Arene Life Sciences (Unit 3) Private Limited?

The compliance status of Arene Life Sciences (Unit 3) Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available